By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Vectura Group plc 

1 Prospect West

Chippenham  Wiltshire  SN14 6FH  United Kingdom
Phone: 44-0-1249-667700 Fax: 44-0-1249-667701


SEARCH JOBS


Industry
Pharmaceutical






Company News
Vectura Group plc (VEC.L) Release: AirFluSal Forspiro Launched In Portugal And Ireland 3/11/2015 10:43:37 AM
Vectura Group plc (VEC.L) Announces Chief Executive’s Intention To Step Down 2/3/2015 9:56:40 AM
Vectura Group plc (VEC.L) Release: Submission Of Regulatory Applications To U.S. FDA And Robust Phase 3 Results For QVA149 And NVA237 1/8/2015 9:40:31 AM
Vectura Group plc (VEC.L) Signs Global Development And Licence Agreement With Janssen Biotech Inc. (JNJ) In Asthma/COPD 1/6/2015 8:55:22 AM
Vectura Group plc (VEC.L)’s Investigational Drug/Device Combination VR475 Met Primary Endpoint And Has Shown Significant Clinical Benefit In A Phase 2b/3 Trial In Severe Asthma Patients 12/11/2014 6:35:04 AM
Vectura Group plc (VEC.L) Release: Approval In Ireland And Czech Republic For Innovative Respiratory Inhaler AirFluSal Forspiro 11/19/2014 9:31:33 AM
Vectura Group plc (VEC.L) Appoints Andrew Oakley As Group CFO 11/18/2014 4:17:10 PM
Vectura Group plc (VEC.L) VR315 U.S. Development Milestone 11/7/2014 9:10:52 AM
Vectura Group plc (VEC.L) Approval In Baltics For Innovative Respiratory Inhaler AirFluSal® Forspiro® 11/4/2014 10:10:20 AM
Vectura Group plc (VEC.L) Release: Approval In Portugal For Innovative Respiratory Inhaler AirFluSal® Forspiro® 10/9/2014 8:08:57 AM
12345678910
//-->